New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...
Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present ...
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. People with pre-clinical obesity are at risk for ...
an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal.The report introduces two new diagnostic ...
GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...